Status:
RECRUITING
Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
Lead Sponsor:
University of Modena and Reggio Emilia
Conditions:
Fibrosis, Pulmonary
Eligibility:
All Genders
18+ years
Brief Summary
Idiopathic Pulmonary Fibrosis (IPF) is a fibrosing progressive interstitial lung disease with unknown etiology, with a median survival of 3 years since first diagnosis. The typical radiologic pattern ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients treated in Center for Rare diseases of Azienda Ospedaliero-Universitaria Policlinico di Modena will be considered eligible if satisfying the following inclusion criteria:
- Patient with IPF and UIP pattern
- Need for radiological evaluation through HRCT
- Exclusione criteria
- Age below 18
- Pregnancy
- Inability to sign informed consent
- COPD
- Neuromuscular diseases
- Evidence of IPF acute exacerbation
Exclusion
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05310669
Start Date
July 1 2023
End Date
July 1 2030
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero Universitaria Policlinico di Modena
Modena, Italy